AgrD is the precursor for the autoinducing peptide in a quorum-sensing system regulating virulence phenotypes of the preeminent pathogen Staphylococcus aureus. Mass spectrometry-based methods, including molecular networking, identified formylated and nonformylated peptide variants derived from the AgrD N-terminal leader domain in S. aureus cell-free culture supernatants. Functional assessment of these peptides revealed unexpected bioactivities, including human cell-line cytotoxicity, modulation of neutrophil chemotaxis, neutrophil extracellular trap formation, and the aggravation of skin lesions in vivo.
INTRODUCTION
Nearly three decades ago, the accessory gene regulatory (Agr) quorum-sensing system was identified in the leading human bacterial pathogen Staphylococcus aureus (Recsei et al., 1986) . A classical model of growth phase-dependent gene regulation, Agr is studied for its important role in regulation of surfaceexpressed or secreted virulence factors. Natural or engineered strains of S. aureus with inactivating mutations in agr genes lose virulence in animal infection (Abdelnour et al., 1993; Villaruz et al., 2009 ). Thus, S. aureus infectivity depends upon an array of Agr-regulated gene products working in concert to circumvent host innate immune clearance (Novick et al., 1993; Pragman and Schlievert, 2004 ), yet many mechanistic details of the Agr system remain a mystery.
Agr quorum-sensing dynamics are governed by the posttranslationally modified, thiolactone-containing autoinducing peptide (AIP) (Enright et al., 2002) . Genetically, agr is composed of two promoters, P2 and P3, which direct the divergent transcription of RNAII and RNAIII according to AIP concentrations. RNAII encodes the four-gene operon agrABCD, and within the cluster, AgrB+AgrD and AgrA+AgrC work together to carry out biosynthesis and regulatory functions. AgrD, the AIP precursor substrate, is cleaved and cyclized through thiolactone formation by cell membrane-bound AgrB. AgrA and AgrC combine to form a kinase-dependent two-component regulatory system. During critical regulatory states, the mature AIP binds extracellularly to the AgrC protein kinase, triggering activation of agrA and successive induction of divergently expressed promoters P2 and P3. RNAIII expression leads to production of two molecules, the primary effector RNA regulator and delta-toxin or phenol-soluble modulin (PSM) g, a wide-spectrum cytolysin that is released extracellularly with a formylated initiator methionine, with a nonformylated methionine, or in truncated forms (Gonzalez et al., 2012) . Taxonomically, S. aureus isolates can be divided into four agr groups on the basis of polymorphisms within the agrABCD operon (Wright et al., 2005) .
Downstream contributions of the mature AIP on S. aureus pathogenesis have been the focus of several studies (Harraghy et al., 2007) . More recently, reports described the biochemistry of each individual gene product and the relationship between the enzyme AgrB and its substrate AgrD (Thoendel and Horswill, 2009) . It is thought that formation of the AIP is initiated by migration of AgrD and its association with the intracellular membrane. The amphipathic AIP N-terminal region contains essential amino acids that stabilize the propeptide, allowing association of core and C-terminal amino acids with AgrB. Endopeptidase AgrB then cleaves the highly conserved C-terminal tail of AgrD to catalyze the formation of a thiolactone ring within the core amino acids. Thereafter, through an unknown mechanism, the AIP precursor is transported across the cell membrane. Once extracellular, the type I signal peptidase SpsB (Kavanaugh et al., 2007) catalyzes the formation of two extracellular final products: (1) AIP and (2) N-terminal peptide ( Figure 1A ).
Using molecular networking (Watrous et al., 2012) , we examined mass spectrometry (MS) data derived from cell-free culture extracts of a representative community-associated methicillinresistant S. aureus (MRSA) USA300 isolate (Kennedy et al., 2010) . Analysis of the molecular network revealed extracellular AgrD N-terminal (termed N-AgrD) formylated and truncated peptide variants. Here we show these N-AgrD variant peptides have immunostimulatory properties toward neutrophils isolated from human blood, display broad-spectrum cytotoxicity, and aggravate skin lesion formation caused by Agr-deficient S. aureus. This study provides insight into endogenous biosynthetic and virulence properties of the Agr quorum-sensing system, while revealing functional properties of AgrD beyond its AIP-encoding domain. Furthermore, we highlight the power of the molecular networking platform as a tool to discover unforeseen bioactive peptides within a long-studied, highly important regulatory system of staphylococcal virulence.
RESULTS

Discovery of N-AgrD Variant Peptides by MS-Based Molecular Networking
Molecular networking is an emerging platform based on the concept of mass spectral pairing, which allows the structural grouping and successive mapping of MS data sets. Recently, our group used the platform to build a molecular network representative of extracellularly released, small molecular weight biosynthetic factors produced by MRSA (Gonzalez et al., 2014) . Here, we report the continued examination of the created molecular network by de novo sequencing and peptidogenomic approaches (Kersten et al., 2011) , recovering peptides pertaining to the AgrD N-terminal domain ( Figure S1 available online). Investigation into the identity of each individual mass spectrum within the AgrD grouped family-produced peptide sequence tags corresponding to N-terminal variants with mass offsets of +28 Da, a signature for formyl-methionine modification. With the recovered chemical knowledge from the molecular networks, we used tandem MS data processing program InsPecT (Tanner et al., 2005) to support the de novo sequencing and peptidogenomics identifications. Careful manual annotation of the identified N-AgrD peptides further validated the identifications ( Figure 1B; Figures S2-S6 ). To broaden our survey, we analyzed 
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Functional Properties of AgrD N-Terminal Peptides cell-free culture extracts of 12 additional S. aureus strains or clinical isolates (Table S1 ). N-AgrD peptides were produced by three USA300 lineage MRSA, two ST59 MRSA , and clonal colony ST45 of USA600 MRSA lineage ( Figure 1C ). In successive MS experiments, peptide sequences most abundantly mapped to AgrD (McIlwain et al., 2012) , herein designated (1) N-AgrD F20, (2) N-AgrD F24, and (3) N-AgrD D20, were synthesized and isolated at >95% purity for functional assessment.
Properties of the N-AgrD Variant Peptides
To estimate the production and release of the N-AgrD variants, MRSA USA300 cell-free cultures were extracted and examined by tandem MS. N-AgrD peptides were detected only in late exponential phase extracts, in agreement with previous reports on the temporal production of the AIP (Junio et al., 2013) . Estimated AIP culture concentrations vary from 2 to 10 mM (Junio et al., 2013) ; therefore, we predicted that N-AgrD peptide variants would be detected in stoichiometric concentrations. We detected 2 to 3 mM N-AgrD F24 in extracted cultures of USA300 strain TCH1516 and 1 to 2 mM in extracted cultures of the ST59 strain. There was increased abundance of N-AgrD peptides upon exposure of MRSA to subinhibitory concentrations of cell-wall active antibiotics daptomycin (0.125 mg/l) or vancomycin (0.125 mg/l), or human cationic defense peptide LL-37 (1.2 mg/l) ( Figure 1D ).
Polymorphonuclear Neutrophil Chemotaxis Induced by N-AgrD Formylated Variants
Leukocytes of the host innate immune system recognize formylated bacterial products as pathogen-associated molecular patterns (Mogensen, 2009) , as mediated through formyl peptide receptors (FPR), a class of G protein-coupled receptors associated with chemotaxis. The human FPR family is composed of three members, FPR1, FPR2/ALX, and FPR3; only the first two are expressed in neutrophils. Recently, members of the S. aureus-derived phenol-soluble modulin (PSM) peptide family were shown to selectively activate FPR2/ALX (Kretschmer et al., 2010) . Because N-AgrD F20 and N-AgrD F24 peptides contained formyl groups, we tested their abilities to act as chemoattractants for human neutrophils. Nanomolar quantities of N-AgrD F20, N-AgrD F24, and N-AgrD D20 were placed in a chamber adjacent to a suspension of freshly isolated neutrophils, and chemotaxis was quantified. Both formylated peptides N-AgrD F20 and F24 showed strong chemoattractant properties comparable with the well-known chemoattractant formyl-methionylleucyl-phenylalanine, whereas nonformylated N-AgrD D20 did not stimulate chemotaxis (Figure 2A ). Using specific antagonists of the FPR1 and FPR2 receptors and calcium influx as a surrogate measure of receptor activation (Dixit et al., 2012) , significant decreases in receptor activation were observed by pharmacological blockade, indicating that the N-AgrD peptides function though a FPR-dependent mechanism ( Figure 2B ).
NET Induction by the N-AgrD F20 Formylated Peptide Neutrophil extracellular trap (NET) formation is a specialized cell death process wherein nuclear DNA is extruded to ensnare and kill pathogens (Brinkmann et al., 2004) . As quantified by DNA release, AgrD F20 strongly stimulated NET formation ( Figure 2C ), whereas no stimulatory effects were observed with peptides NAgrD F24 and N-AgrD D20. N-AgrD F20 stimulation of NETs was corroborated by fluorescence microscopy, which showed the hallmark weblike NET structures were formed by neutrophils upon N-AgrD F20 stimulation ( Figure 2D ).
N-AgrD Variant Peptides Cytotoxicity against Human Cell Lines and Erythrocytes
Hemolytic ability of the N-AgrD peptides was tested against erythrocytes from freshly washed human blood. N-AgrD F20 and N-AgrD F24 showed significant hemolytic activity, but NAgrD D20 peptide did not induce erythrocyte lysis ( Figure 3A) . USA300 MRSA are associated with complicated skin and soft tissue infections and severe necrotizing pneumonia, as the pathogen breaks down host epithelial tissue barriers (Lim et al., 2012; Wang et al., 2007) . We tested the effect of micromolar concentrations of N-AgrD peptides on a human alveolar epithelial cell line (A549) and a human keratinocyte cell line (HaCaT). As measured by lactate dehydrogenase (LDH) release, N-AgrD F20 and N-AgrD F24 formylated peptides exhibited twice the cytolytic activity against both tissue cell lines as the nonformylated N-AgrD peptide ( Figures 3B and 3C ). A549 and HaCaT cytotoxicity was corroborated by live/dead cell counts (Figures S7A and S7B) and visual assessment by microscopy ( Figure 3D; Figure S7C) . Additionally, a scrambled-sequence peptide was included as a negative control and showed no activity, verifying that N-AgrD bioactivity is sequence-specific.
N-AgrD Peptides Aggravate Skin Lesions in a Murine
Model S. aureus is the most common cause of skin and soft tissue infections in humans, and the majority of the isolates cultured from these infections are predominately agr positive. We sought to determine the contribution of N-AgrD peptides to disease progression in vivo independent of the well-established role of the Agr system in virulence. To that end, we inoculated mice subcutaneously with the agr null strain S. aureus RN6911 in the presence or absence of a micromolar mixture of the N-AgrD F20 and N-AgrD F24. Presence of the N-AgrD peptides significantly increased ensuing lesion sizes ( Figure 3E ). After 72 hr, the lesion sizes caused by the RN6911 strain harvesting the N-AgrD peptides were approximately double in size ( Figures 3E and 3F ) despite equal bacterial loads ( Figure S8) , consistent with the endogenous proinflammatory and cytotoxic properties of these peptides observed in our in vitro testing. Permission to undertake experiments was obtained from the Animal Subject Ethics Committee of the University of California, San Diego. 
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Functional Properties of AgrD N-Terminal Peptides membrane anchoring and successive processing by AgrB (Zhang et al., 2004) . Our study shows the extracellular release of N-AgrD as a set of bioactive structurally diverse peptides, including formylated variants. These findings indicate that S. aureus has evolved to maximize or chemically salvage its protein repertoire in order to gain ecological fitness. N-AgrD structurally resembles the PSM toxin family in S. aureus. PSMs are cytolytic, formylated and nonformylated peptide variants that are upregulated in community-associated MRSA and genetically linked to the agr system (PSMg is embedded within RNAIII) (Wang et al., 2007; Gonzalez et al., 2014) . Because of the structural similarities between peptides, N-AgrD could play a potential role in biofilm structural formation as demonstrated for PSMs (Periasamy et al., 2012) . In concurrence with the work herein, N-AgrD was recently shown to be a constituent of amyloid fibrils of biofilms and possess further cellular functions akin to PSMs (Schwartz et al., 2014) .
Mechanisms governing the amounts of N-AgrD participating in amyloid fibrils (biofilm) versus free to the surrounding environment is likely a dynamic process governed by environmental stimuli. This notion is supported by our observation that subinhibitory concentrations of cell-wall inhibiting antibiotics or LL-37 increased abundance of N-AgrD peptides in a similar manner to PSMs (Gonzalez et al., 2012) . The interplay between promiscuous S. aureus exoproteases and the AgrD leader domain may lead to the wide repertoire of N-AgrD variants. Proteolysis studies on the AIP showed S. aureus supernatants produced variant cleavage products of the N-terminal AgrD domain independent of SpsB (Kavanaugh et al., 2007) . Our accumulated studies on the AgrD leader domain show unforeseen, yet important components of the now classical agr pathway.
In summary, we applied MS-based tools to identify N-AgrD variants that possess cytotoxic and proinflammatory activities. These peptides potentially modulate S. aureus disease manifestations, and suggest that the N-terminal leader domain of this protein is not simply an innocuous castoff during processing of the mature AIP. Like many pattern recognition molecules with mixed proinflammatory and toxic activities, their effect on the host is complex and likely to vary dependent on the site, stage, and magnitude of infection. Therefore, the effects N-AgrD variants have on S. aureus gene regulation (i.e., AgrAAgrC signaling) merits further study. Ultimately, this work exemplifies the use of an emerging tool like molecular networking can aid in elucidating molecules that influence the establishment of infection, leading to better understanding their broader impact on the pathogen-host interaction.
SIGNIFICANCE
Our results reveal that the N-terminal leader end of the AIP substrate AgrD is an extracellularly released peptide existing in variant forms with unexpected bioactivities in vitro and in vivo. These peptides may play a role in MRSA virulence; before this study, only the core amino acids of mature AgrD were believed to contribute to bacterium's pathogenic cycle. This project arose by the application of the new and emerging tool of MS-based molecular networking, which highlights the value of integrating cutting-edge analytical tools to the study of biological systems. Because the complex array of virulence factors produced by MRSA is not fully understood, it is critical to apply new strategies that extend beyond the classical paradigm of proteomic identification. These new technologies can lead to unforeseen information on the molecular repertoire of human pathogens.
EXPERIMENTAL PROCEDURES
Identification of N-AgrD by MS S. aureus cultures (Table S1 ) were grown in Todd-Hewitt broth at 37 C to late exponential-early stationary growth phase and pelleted at 4,000 rpm 3 10 min, and 1 ml supernatant was collected, extracted with an equal volume of 1-butanol, and dried by SpeedVac. SDS-PAGE gels showed no Coomassie staining indicative of larger proteins; therefore, the extracts were considered to contain peptides and other small molecular weight species. Solid extracts were resuspended and processed by Thermo-Finnegan linear trap quadruple liquid chromatography tandem MS. Peptidogenomic annotation of the collected tandem MS data indicated sequence tags of the N-AgrD, and mass offsets of +28 Da were localized to the N-terminal methionine residue. Targeted use of the MS processing program InsPecT identified several NAgrD variant peptides with formylated initiator methionine residues. Here we focused on the three most abundant and highest scoring peptides obtained from InsPecT, after validation of the assignments by manual annotation.
Synthetic Peptides
The following peptides were synthesized by American Peptide: (1 Supplemental Table S1 , related to Figure 1 Staphylococcus aureus strains in AgrD peptide screen 2
Supplemental Figures
Supplemental Figure S1 , related to Figure aureus agr null strain was tested +/-addition of a 1:1 mixture of AgrD F20 and AgrD F24 (10 μg/ml) on contralateral flanks; each mouse served as its own control. Statistical analysis was performed by Student's T-test; nonsignificant. This contrasts with increased lesion size associated with AgrD peptide treatment.
